Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple-ascending Dose Clinical Trial of the Safety and Tolerability of Antioxidant (AT-001) Treatment for Reducing Brain Oxidative Stress

NCT01731093 is registered in ClinicalTrials.gov with Alltech Life Sciences Inc. as lead sponsor.

NCT NCT01731093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01731093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple-ascending Dose Clinical Trial of the Safety and Tolerability of Antioxidant (AT-001) Treatment for Reducing Brain Oxidative Stress
Lead sponsor
Alltech Life Sciences Inc.
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2012
Completion date
December 31, 2013
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oxidative stress